Tricyclic antidepressants and mecamylamine bind to different sites in the human α4β2 nicotinic receptor ion channel
- 9 March 2010
- journal article
- research article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 42 (6), 1007-1018
- https://doi.org/10.1016/j.biocel.2010.03.002
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Different interaction between tricyclic antidepressants and mecamylamine with the human α3β4 nicotinic acetylcholine receptor ion channelNeurochemistry International, 2010
- Interaction of Bupropion with Muscle-Type Nicotinic Acetylcholine Receptors in Different Conformational StatesBiochemistry, 2009
- Probing the Structure of the Affinity-Purified and Lipid-Reconstituted Torpedo Nicotinic Acetylcholine ReceptorBiochemistry, 2008
- Allosteric modifiers of neuronal nicotinic acetylcholine receptors: New methods, new opportunitiesMedicinal Research Reviews, 2007
- Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptorsThe International Journal of Biochemistry & Cell Biology, 2006
- Refined Structure of the Nicotinic Acetylcholine Receptor at 4Å ResolutionJournal of Molecular Biology, 2004
- Nicotine and nicotinic receptor antagonists potentiate the antidepressant‐like effects of imipramine and citalopramBritish Journal of Pharmacology, 2003
- M2 mutations of the nicotinic acetylcholine receptor increase the potency of the non-competitive inhibitor phencyclidineJournal of Neuroscience Research, 2000
- Snake venom toxins, unlike smaller antagonists, appear to stabilize a resting state conformation of the nicotinic acetylcholine receptorBiochimica et Biophysica Acta (BBA) - Biomembranes, 1995
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973